Skip to main content

Advertisement

SpringerLink
Log in

Laparoscopic gastrectomy: advances enable wide clinical application

  • Letter
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Singh KK, Rohatgi A, Rybinkina I, McCulloch P, Mudan S (2007) Laparoscopic gastrectomy for gastric cancer: early experience among the elderly. Surg Endosc Epub 2007 Sept 2

  2. Lee JH, Kim YW, Ryu KW et al (2007) A phase-II clinical trial of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for gastric cancer patients. Ann Surg Oncol 14(11):3148–3153

    Article  PubMed  Google Scholar 

  3. Ziogas D, Baltogiannis G, Fatouros M, Roukos DH (2008) Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann Surg 247(4):714–715

    Article  PubMed  Google Scholar 

  4. Francis WP, Rodrigues DM, Perez NE, Lonardo F, Weaver D, Webber JD (2007) Prophylactic laparoscopic-assisted total gastrectomy for hereditary diffuse gastric cancer. JSLS 11:142–147

    PubMed  Google Scholar 

  5. Roukos DH, Hottenrott C, Lorenz M, Koutsogiorgascouchell S (1990) A critical evaluation of effectivity of extended lymphadenectomy in patients with carcinoma of the stomach: an analysis of early results and long-term survival. J Cancer Res Clin 116:307–313

    Article  CAS  Google Scholar 

  6. Siewert JR, Bottcher K, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228:449–461

    Article  PubMed  CAS  Google Scholar 

  7. Roukos DH, Kappas AM (2002) Targeting the optimal extent of lymph node dissection for gastric cancer. J Surg Oncol 81:59–62

    Article  PubMed  Google Scholar 

  8. Kappas AM, Fatouros M, Roukos DH (2004) Is it time to change surgical strategy for gastric cancer in the United States? Ann Surg Oncol 11:727–730

    Article  PubMed  Google Scholar 

  9. Sano T (2007) Tailoring treatments for curable gastric cancer. Br J Surg 94:263–264

    Article  PubMed  CAS  Google Scholar 

  10. Wu CW, Hsiung SA, Lo et al (2006) Nodal dissection for patients with gastric cancer: a randomised trial. Lancet Oncol 7:309–315

  11. Roukos DH (2004) Early-stage gastric cancer: a highly treatable disease. Ann Surg Oncol 11:127–129

    Article  PubMed  Google Scholar 

  12. Roukos DH, Hottenrott C, Encke A, Baltogiannis G, Casioumis D (1994) Primary gastric lymphomas: a clinicopathologic study with literature review. Surg Oncol 3:115–125

    Article  PubMed  CAS  Google Scholar 

  13. Gervasoni JE Jr, Sbayi S, Cady B (2007) Role of lymphadenectomy in surgical treatment of solid tumors: an update on the clinical data. Ann Surg Oncol 14(9):2443–2462

    Article  PubMed  Google Scholar 

  14. Roukos DH, Kappas AM (2005) Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2:98–107

    Article  PubMed  Google Scholar 

  15. Roukos DH (1998) Extended lymphadenectomy in gastric cancer: when, for whom, and why. Ann R Coll Surg Engl 80:16–24

    PubMed  CAS  Google Scholar 

  16. Roukos DH (2000) Extended (D2) lymph node dissection for gastric cancer: do patients benefit? Ann Surg Oncol 7:253–255

    Article  PubMed  CAS  Google Scholar 

  17. Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725–730

    Article  PubMed  CAS  Google Scholar 

  18. Roukos DH (2002) Adjuvant chemoradiotherapy in gastric cancer: wave goodbye to extensive surgery? Ann Surg Oncol 9:220–221

    Article  PubMed  Google Scholar 

  19. Shehzad K, Mohiuddin K, Nizami S et al (2007) Current status of minimal access surgery for gastric cancer. Surg Oncol 16:85–98. Epub 2007 Jun 7

    Article  PubMed  Google Scholar 

  20. Norton JA, Ham CM, Van Dam J et al (2007) CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann Surg 245:873–879

    Article  PubMed  Google Scholar 

  21. Chung DC, Yoon SS, Lauwers GY, Patel D (2007) Case records of the Massachusetts General Hospital: Case 22-2007: A woman with a family history of gastric and breast cancer. N Engl J Med 357:283–291

    Article  PubMed  CAS  Google Scholar 

  22. Roukos DH, Murray S, Briasoulis E (2007) Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancer. Cancer Biol Ther 6:308–312

    Article  PubMed  CAS  Google Scholar 

  23. Kim JJ, Song KY, Chin HM (2008) Totally laparoscopic gastrectomy with various types of intracorporeal anastomosis using laparoscopic linear staplers: preliminary experience. Surg Endosc 22(2):436–442

    Article  PubMed  Google Scholar 

  24. Roukos DH, Briasoulis E (2007) Individualized preventive and therapeutic management of hereditary breast ovarian cancer. Nat Clin Pract Oncol 4:578–590

    Article  PubMed  CAS  Google Scholar 

  25. Roukos DH, Kappas AM, Tsianos E (2002) Role of surgery in the prophylaxis of hereditary cancer syndromes. Ann Surg Oncol 9:607–609

    PubMed  Google Scholar 

  26. Roukos DH, Agnanti NJ, Paraskevaidis E, Kappas AM (2002) Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations. Ann Surg Oncol 9:941–943

    PubMed  Google Scholar 

  27. Ratouros M, Baltoyiannis G, Roukos DH (2008) The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Ann Surg Oncol 15(1):21–33

    Article  Google Scholar 

  28. Agnantis NJ, Paraskevaidis E, Roukos D (2004) Preventing breast, ovarian cancer in BRCA carriers: rationale of prophylactic surgery and promises of surveillance. Ann Surg Oncol 11:1030–1034

    Article  PubMed  Google Scholar 

  29. Roukos DH (2007) Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 357(15):1555-1556 author reply 1556

    Google Scholar 

  30. Roukos DH (2008) Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies. Expert Rev Mol Diagn 8(1): 29–39

    Article  PubMed  CAS  Google Scholar 

  31. Liakakos T, Roukos DH (2008). More controversy than ever-challenges and promises towards personalized treatment of gastric cancer. Ann Surg Oncol 15(4): 956–960

    Article  PubMed  Google Scholar 

  32. Roukos DH (2008) HER2 and response to paclitaxel in node-positive breast cancer. N Engl J Med 358:197 author reply 198

    Google Scholar 

  33. Roukos DH (2008) Linking contralateral breast cancer with genetics. Radiother Oncol 86:139–141

    Article  PubMed  Google Scholar 

  34. Roukos DH (2008) Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med (in press)

Download references

Author information

Authors and Affiliations

  1. Third Surgical Department, University of Athens, Athens, Greece

    T. Liakakos

  2. Surgical Department, University of Ioannina, Ioannina, Greece

    D. Roukos

Authors
  1. T. Liakakos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Roukos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Liakakos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liakakos, T., Roukos, D. Laparoscopic gastrectomy: advances enable wide clinical application. Surg Endosc 22, 1553–1555 (2008). https://doi.org/10.1007/s00464-008-9869-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-008-9869-0

Keywords

Search

Navigation